New Research Highlights Advances in Psychiatric Treatment

BY MARK MORAN

Seven cutting edge researchers presented original research relevant to psychiatry and psychiatric patients at a special presentation chaired by Jeffrey Borenstein, M.D., editor of Psychiatric News. Ronit Kedem Dedesma, M.D., consultation-liaison psychiatrist at Cambridge Health Alliance and instructor at Harvard Medical School, discussed her research on, “Using an Electronic Medical Record to Improve Monitoring for Patients on Antipsychotic Medicines.” Dr. Dedesma said patients with serious mental illness (SMI) are less likely to receive adequate management of diabetes, high cholesterol, and heart disease, and noted that antipsychotic medications used to treat SMI increase the risk of diabetes and other health problems.

She described an effort at Cambridge Health Alliance to use electronic medical records (EMR) to provide education and reminders about the need to monitor for metabolic status in patients with SMI for clinicians in family medicine, internal medicine, and psychiatry. However, between 2010 and 2011, there was no significant difference in clinician behavior with regard to monitoring metabolic status, suggesting the need to further refine efforts. “Rates of monitoring patients on antipsychotics for metabolic parameters is suboptimal and our interventions have not yet been effective,” she said. “We are working to implement more EMR tools and systems changes to increase awareness and follow through.”

Peter J. Neumann, Sc.D., Director of the Center for the Evaluation of Value and Risk in Health at the Institute for Clinical Research and Health Policy Studies at Tufts Medical Center and Professor of Medicine at Tufts University School of Medicine, talked about his research looking at “The Hidden Costs of Attention Deficit/Hyperactivity Disorder.” He found that while the magnitude of estimates varies widely – with incremental costs of ADHD ranging between $101 – $163 billion – overall the analysis indicates that ADHD is associated with a substantial individual and societal economic impact. Dr. Neumann said the major cost drivers are work-related costs: income losses due to lower wages and unemployment and education-related costs. “Results indicate need for policies that incentivize third-party payers to consider all cost sectors when evaluating cost-effectiveness of coverage and ADHD treatments,” he said.

Umesh Vyas, M.D., Chair of the Department of Psychiatry and Medical Director of the Behavioral Health Unit and Medical Director of Sleep Disorders Center, Mayo Clinic Health System, described his research on “Treating Sleep Disorders has Positive Outcomes in Psychiatric Illness.”

He performed a review of electronic medical records for diagnosis of sleep disorders at Clement J. Zablocki VA Medical Center in Milwaukee from October 2007 to December 2007. Patients with confirmed diagnosis and treatment for sleep disorders were included and outcomes in patients with comorbid psychiatric disorders were recorded at 6, 12 and 24 months after initiation of sleep disorder treatment.

He found that treatment of comorbid sleep disorders was associated with significant improvement in psychiatric disorders and that psychiatric disorders did not affect compliance with sleep disorders treatment. Dr. Vyas noted that there is a strong need for prospective studies with more subjects.

Other presenters included Abid Malik, M.D., Medical Director at the Sleep Disorder Center, South Seminole Hospital of Orlando Health; David Tran, a medical student at David Geffen School of Medicine at UCLA; Janet Williams, Ph.D., Vice President of Clinical Development, MedAvante, Inc.; and Dinesh Mittal, M.D., Associate Professor, Department of Psychiatry and Behavioral Sciences, College of Medicine, University of Arkansas for Medical Sciences.

Symposium Focuses on Mindfulness in Stress Treatment

BY MARK MORAN

Mindfulness — the practice of training the mind to be fully attentive to the present moment, without judgment — has in the last two decades entered the lexicon of medicine, psychiatry, and social work with the potential to transform the way we think of mind, body and healing.

That’s what Jon Kabat-Zinn, Ph.D., Professor of Medicine Emeritus at the University of Massachusetts Medical School, told psychiatrists Saturday during a presidential symposium on “Mindfulness-Based Practices in the Treatment of Stress and Psychiatric Illness at APA’s Annual Meeting in Philadelphia.

“We are at a momentous crossroads in all of the various medical disciplines that have to do with the mind and brain and how we understand the brain in relationship to what we call the mind and what we call the body, and what we call community and how we relate to each other,” Dr. Kabat-Zinn said. “There are remarkable studies going on [with subjects] across the age span in which learning how to be more present and more accepting and clearer about our own experience and not being caught in the usual traps can be profoundly liberating and preventative.”

Dr. Kabat-Zinn, a renowned author and founding director of the Stress Reduction Clinic and the Center for Mindfulness in Medicine, Health Care, and Society at the University of Massachusetts Medical School, has merged his early interest in and practice of Zen Bhuddist meditation with Western medicine to help people cope with stress, anxiety, pain, and illness. During Saturday’s symposium, Dr. Kabat-Zinn spoke on “Mindfulness-Based Stress Reduction (MBSR): What It Is and Its Clinical Applications for Stress, Pain, and Chronic Illness.”

Other speakers included Peter Beiling, Ph.D., director of mental health and addictions at St. Joseph’s Healthcare in Ontario, John W. Denninger, M.D., Ph.D., director of research at the Benson-Henry Institute for Mind Body Medicine at Massachusetts General Hospital, and Sara Lazar, Ph.D., neuroimaging researcher at Harvard Medical School.

Dr. Kabat-Zinn spoke at length about what mindfulness is — and what it is not — and he cautioned that what it is not is merely another form of cognitive therapy. Rather, it is a “way of being,” a practice of being fully awake to the present moment that is ultimately very hard to learn and quite at odds with the distracted multi-tasking culture of western society. “…It’s easier said than done. The first thing you notice when you cultivate mindfulness is how mindless we are,” he said. “This turns out to be the hardest thing for us to do — to be present and to string moments of presence together.”

But he said that the understanding and practice of mindfulness has begun to transform Western society and healing practices in a way that could not have been imagined 50 years ago. “Carl Jung said the methods and philosophical doctrines that have developed in this regard simply put all Western efforts to shame,” Dr. Kabat-Zinn said. “So he was very impressed by [Eastern concepts of mindfulness], but he also said that there was no way a Westerner could ever understand this. He said there was a cultural divide between what we quaintly called the East and West…But if he came back now, he would be completely mind-blown. Today you can say there is more interest in mindfulness in the West than there is in the East.”

He added, “I think it is diagnostic that APA is having this presidential symposium and what would be really fun is to come back in 10 years and see how it has all unfolded.”

Disparities Affect Black Males

Correcting educational and health disparities and addressing undiagnosed mental health needs in the African American community will be vital in overcoming the increasing incarceration rates of black males and juveniles in the United States. This was the conclusion of a panel of experts who discussed untreated mental disorders in this population yesterday morning during a workshop titled “Incarceration of Black Males: The Effects of Untreated Bipolar, ADHD, and Substance Abuse Disorders.”

In addition, cultural roadblocks, media depictions of the “super thug,” and the booming prison industry all contribute to the acceptance of over-incarceration of black males in America, the panel agreed.

“At any given time, one-third of black men are in the legal system, including incarceration, probation, or parole,” said Otis Anderson, M.D., a psychiatric specialist with Tri-Lakes Behavioral Health, Batesville, Miss. “There’s a huge industry in locking people up.”

Napoleon B. Higgins, M.D., CEO and President of Baypoint Behavioral Health Services in Houston, presented chilling statistics of the overwhelming growth of the penal system in Texas. Between 1980 and 2004, there was a 566 percent increase in the prison population and a 1,600 percent increase in corrections spending, he said.

Drug use is often cited as cause for the overabundance of black males in the prison system, Dr. Higgins said. However, African Americans make up only 13 percent of daily drug users in the U.S., he said, even though they represent the vast majority of the prison population.

Arrest statistics also paint a troubling picture. For example, 55 percent of crack users in the United States are white but 74 percent of people incarcerated for crack use are black, Dr. Higgins said.

“Drugs are an excuse to put black people in jail,” Dr. Higgins said. “Disparities exist in drug-related incarcerations. Police are hunting out black males because they are the face of violent crime in the media.”

Indeed, all of the panelists cited media depictions of the black male as a violent crime instigator as one of the leading factors contributing to the growing imprisonment of African Americans. “In media and rap music, essentially you can be aggressive, violent, and hypersexual with no consequences to behavior,” Dr. Higgins said. “The promotion of that manic-type ‘super thug’ drives a lot of kids to believe that people actually live like that.”

When black males are incarcerated, there is a lack of diligence in diagnosing and treating mental illness and disorders, said Rahn K. Bailey, M.D., Chairman of Psychiatry and Behavioral Sciences at Meharry Medical College, Nashville. But in many cases, mental disorders such as ADHD that could have been diagnosed and treated in childhood are left undiscovered until a person has landed in the penal system.

“The reality is African American males are people, too,” Dr. Bailey said. “They have clinical psychiatric illnesses such as ADD, ADHD, bipolar disorder, and schizophrenia and they need to be treated.”

Dr. Bailey advocates for early diagnosis and treatment, but says cultural issues within the black community provide a roadblock for early intervention and treatment of many mental disorders. For example, there’s a huge social stigma attached to ADHD diagnosis and treatment.

“Parents need to be educated that this is not a bad thing or an albatross around their child’s neck,” said Dr. Bailey, who also cited the need for psychiatric organizations working with minority patients to make sure the information distributed in the community is appropriate and culturally sensitive.

When a diagnosis is made and treatment is offered, other challenges include cultural, environmental, ethnic, and genetic factors that play into the toxicity, metabolism, and side effects of medication.

Johnny Williamson, M.D., Chief Medical Officer Clinical Director of the Pediatric Psychiatric Unit at Hartgrove Hospital, Chicago, highlighted some of the drug-related interactions associated with genetic and cultural factors. For example, African American children are more likely to experience high blood pressure when taking a stimulant for ADHD, he said.

Dr. Williamson recommended rational psychopharmacotherapy, treating each person individually, discussing the factors that will impact treatment, and establishing an effective treatment alliance. “I’ve only seen a positive benefit when I’ve been able to be knowledgeable about, discuss, and include in my treatment some aspect of talking about what a person’s culture, desires, preferences, and understandings are,” he said.

APA National Election

Each year the membership of the APA elects members to the Board of Trustees to undertake the responsibility of governing the Association. While the power to make policy is vested in the Board, their primary function is to formulate and implement the policies of the Association. Please take a moment to exercise one of your member benefits and participate in the nomination and election of the Association’s leadership.Nominations and letters of recommendation can be submitted to election@psych.org.

The slate of candidates is announced on the APA website, www.psychiatry.org, November 1. Eligible voting members can expect to vote with an e-mailed electronic ballot or mailed paper ballot during the month of January. Mark your calendars!

OPEN OFFICES FOR 2013 ELECTION

  • President-Elect
  • Secretary
  • Area 3 Trustee
  • Area 6 Trustee
  • Minority/Under-Represented (M/UR) Trustee
  • Member-in-Training Trustee-Elect (MITTE)

OPEN OFFICES FOR 2014 ELECTION

  • President-Elect
  • Treasurer
  • Area 2 Trustee
  • Area 5 Trustee
  • Trustee-at-Large
  • Member-in-Training Trustee-Elect (MITTE)

 

U.S. Army Launches Clinical Trial Series to Advance Treatment of Combat-Related PTSD

Seeking to improve outcomes for patients with combat-related Post-Traumatic Stress Disorder (PTSD), the U.S. Army is leading a new research initiative that will examine the efficacy of multiple FDA-approved pharmacotherapeutics.

This multi-year, multi-site series of clinical trials will systematically evaluate a range of pharmaceuticals. The first trial, scheduled to start enrolling patients in 2013, will evaluate the utility of several commonly prescribed drugs currently used off-label to treat PTSD or major PTSD symptom clusters.

“We’re trying to advance the science to catch up with clinical practice,” said Maj. Gary H. Wynn, M.D., research psychiatrist, Center for Military Psychiatry and Neuroscience at the Walter Reed Army Institute of Research. “Much of the current pharmacologic treatment of combat-related PTSD is off-label and, while there are anecdotal information and small trials supporting that usage, this effort will seek to provide clinicians with a higher level of evidence when choosing a drug.”

Maj. Wynn and Col. David M. Benedek, M.D., professor/deputy chair, Department of Psychiatry, and associate director, Center for the Study of Traumatic Stress, at the Uniformed Services University of the Health Sciences, highlighted this new initiative during the Advances in Series 2: Advances in Post- Traumatic Stress Disorder session here in Philadelphia. The effort will involve dozens of military and collaborator medical facilities and hundreds of patients.

The Army has long supported clinicians determining the best treatment plan based on individual patient needs – whether that includes psychotherapy, a medication or both. Yet, the lack of evidence-based guidelines for medication management of PTSD is a key driver for this large-scale effort to study the ability of various pharmaceuticals to ease PTSD symptoms.

“The overall goal will be to provide better guidance to clinicians who treat combat-related PTSD so service members and veterans receive the highest level of care,” said Maj. Wynn. “For pharmaceuticals that show benefits in treating combat-related PTSD, the Department of Defense may work toward a new indication or change in labeling.”

The Army plans to publish results from the first trial in 2016 and share ongoing study findings with the broader behavioral health community at future medical meetings. As appropriate, the Army also will submit findings from this initiative to the Food and Drug Administration to support potential new indications for select, FDA-approved medications.

According to Maj. Wynn, future trials may also include development of novel compounds that show promise in treating combat-related PTSD in order to increase the treatment options at a clinician’s disposal. Ultimately, this initiative may help advance clinical practice guidelines and drive more effective treatment for both military and civilian patients suffering from PTSD.

Lecturer Hopes DSM-5 Will Lead to Innovation in Research, Practice

For Steven E. Hyman, M.D., one of this year’s APA Distinguished Psychiatrist Lecturers, the upcoming publication of DSM-5 is just a beginning. He said he hopes the document, which is due to be published in May 2013, will lead to greater innovation in psychiatric research and practice.

“We need find ways of unshackling science that will encourage scientists to recluster and create a diagnostic system from the bottom up,” said Dr. Hyman, who will discuss how the DSM-5 will affect the future of psychiatric practice and research at 11 a.m. today in Room 115A-C, Level 1, Pennsylvania Convention Center. His lecture is titled “Can We Safely Deliver the DSM-5 Into the 21st Century?”

One of the expected changes in the DSM-5 is the introduction of dimensional diagnoses, such as within the autism spectrum, which has garnered notice in the popular press. “The science tells us most of the disorders we have are not categories,” Dr. Hyman said. “Fundamentally, the DSM-3 had too many individual categories when, in fact, the world is better represented by dimensions and probably larger grouping.”

The DSM-3, published in 1980, is considered a foundation work that led to significant successes in psychiatric research and clinical practice over the last few decades. But it was based on science of the 1960s and 1970s.

“It is not surprising we are discovering substantial problems with its organization,” said Dr. Hyman, Director of the Stanley Center for Psychiatric Research at the Broad Institute and Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. “The core problem that the intellectual forbearers of the DSM-3 couldn’t foresee is the genetic complexity of psychiatric disorders.”

The lack of objective medical tests for the vast majority of disorders listed in the manual led to the creation of operationalized diagnostic criteria. This enhanced interrater reliability and helped psychiatrists agree on diagnoses. But research into the genetic factors of mental disease has made the categorization of mental disorders too simplistic.

“The DSM-3 was a brilliant document that could not have foreseen the science,” Dr. Hyman said. “It’s time to move on scientifically.”

In some ways, the DSM-3 also hindered innovation, Dr. Hyman said. Researchers seeking National Institutes of Health grants or trying to publish in a top journal have to follow DSM criteria. But in some ways, those researchers could never get outside the DSM criteria and look at other ways of classifying psychopathology.

“For example, it was very hard to get a grant to test the hypothesis that maybe the apparent comorbidity of multiple anxiety disorder and mood disorders was just that there was a single underlying process or single disorder that got expressed with different symptom complexes in different times in life, or depending upon different environments or context one lived in,” Dr. Hyman explained.

AWP Breakfast Will Honor Former Leader

The Association of Women Psychiatrists (AWP) will honor the late Tana Grady- Weliky, M.D., a past AWP president, during its Women’s Networking & Mentoring Breakfast tomorrow at 7:30 a.m. in Room 501A, Level 5, Philadelphia Marriot Downtown.

“This event was extremely well attended last year and is a wonderful tribute to the memory and work of our esteemed colleague who cared deeply about the continued advancement of women in psychiatry,” said Patricia Isbell Ordorica, M.D., AWP President.

AWP to Present Social Justice Award

The Association of Women Psychiatrists (AWP) will honor Donna M. Norris, M.D., with the 2012 Jeanne M. Spurlock, M.D. Social Justice Award at the AWP Annual Awards Evening and joint meeting with APA’s Women’s Caucus today at 5:30 p.m. in the Grand Ballroom, Salon A, Level 5, Philadelphia Marriott Downtown.

Dr. Norris is being honored with this award for her extraordinary dedication to and creative leadership efforts in the personal and professional development of women and minorities. Dr. Norris is the editor of the recently published book, “Women in Psychiatry: Personal Perspectives.”

APA President John M. Oldham, M.D., Reflects on Year in Leadership

Immediate Past President Bernstein, President-Elect Jeste, Speaker Sullivan, members of the board and the assembly, past presidents, and distinguished guests: it is my privilege to welcome you to the 165th Annual Meeting of the American Psychiatric Association.

I am especially pleased that our meeting this year takes place in Philadelphia, the birthplace of Benjamin Rush, who is often referred to as the “father of modern psychiatry.”

Rush was one of the five physician signers of the declaration of independence, and he was a pioneering thinker in our field.

To quote Walter Barton from his volume on the history of the APA, “Rush believed that mental illness was a disorder of the total person, with an origin in bodily impairment and in emotionally stressful events.” Today, we might use words like “the stress/ vulnerability model of disease,” or “bi-directional gene/ environment interaction,” to describe the same basic concept, now supported by solid research findings. Yet these early words of Rush seem fresh and cogent today, right on target with the theme of this meeting, which I’ll expand to call “patient-centered, integrated care.”

You remember the four principles I listed last year as particularly important priorities for the APA:

  1. Psychiatry is part of the house of medicine,
  2. Our patients have a right to quality treatment,
  3. Fragmented care is not quality care, and
  4. Research and education provide the best blueprint for our future.

Rather than comment on each of these one by one, as I did last year, I’d like to consider them together, as critical elements of our goal to achieve high quality, evidence-based, patient-centered integrated care, as we strive to be as effective as we can in a complex time of health care reform.

One of my favorite off Broadway productions from many, many years ago was a little musical called “In Circles,” which put words of Gertrude Stein to music. Stein said, “A circle is a necessity. Otherwise you would see no one.” I like that quote. It reminds us to remember where we’ve been, and to wonder if our brand new ideas may not be so new after all. So I decided to circle back and take a look at our last decade.

The APA met in Philadelphia 10 years ago, in 2002, and Richard Harding, M.D. was our President. In his presidential address, he said, “where will we get the will to create integrated public/ private health care systems that will equitably and professionally deliver care to with mental illness, including substance use disorders?” He went on to say that the task will be “incremental,” that we “must be in it for the long haul,” and that we have “an unmatched scientific knowledge base that will lead us to new treatment resources and health care delivery systems.” In response to his address, President-Elect Paul Appelbaum, M.D. described the systematic defunding of psychiatric care as “a crisis at our doorstep.” Among many areas of concern, Dr. Appelbaum stated that “the federal government decided that the goal of a balanced budget could be reached only by cutting back Medicare payments, especially to teaching hospitals.”

We all remember the cascade of events following the balanced budget act and its impact on teaching hospitals. But this sounds awfully familiar today, as we monitor the federal budget deficit reduction process, with graduate medical education perilously in the cross-hairs, and with budgets everywhere dealing only with cuts. Here’s one example; I recently obtained data from the National Association of State Mental Health program directors showing that from just 2009 to the present, the total reduction in funding to state mental health administrations nationwide is estimated to be 3.4 billion dollars. Not to mention the seemingly insoluble sustainable growth rate problem that would cost hundreds of billions of dollars to fix. So remembering Dr. Appelbaum’s 2002 metaphor, I believe the crisis is no longer at our doorstep but is through the door and in the room with us.

I’d like to change the subject from the crises of today, but let’s keep looking back for a bit longer. When Dr. Applebaum became President, he appointed a task force chaired by Steve Sharfstein, M.D. to develop “a vision for the mental health system.” The task force report was presented to the Board of Trustees in March, 2003. The following year, President Marcia Goin M.D. appointed a work group to actuate the vision statement, chaired by Dr. Appelbaum, which presented its report to the Board of Trustees in March, 2004. Both of these documents are thoughtful and comprehensive, and they remain remarkably relevant today.

Dr. Sharfstein’s report stated that mental health care should be fully integrated with the treatment of substance abuse disorders, primary care and other general medical services. In turn, Dr. Appelbaum’s report stated that most Americans have a primary care physician who should be their point of entry to needed mental health treatment. Many persons with mental disorders can be given a diagnosis and be treated in the primary care system, especially if psychiatric consultation and referral of the more difficult cases is readily available.

It is interesting, in the spirit of circling back, to re-visit these aspects of our APA vision and to evaluate how we have done. In my judgment we’ve done pretty well, though better in some areas than in others. Sometimes very good ideas, such as integrated care, are ahead of their time, or they are impeded by fiscal and political circumstances, and we need to be in it for the long haul.

A position statement entitled “Principles for Health Care Reform for Psychiatry” was approved by the APA Board of Trustees in 2008. It derived from the earlier Drs. Sharfstein and Appelbaum reports, and it emphasized that psychiatry should be integrated with medicine in primary care settings and hospitals. APA followed this position statement with a report on the integration of psychiatry and primary care in 2009, which stressed that integrated care, is more than the simple co-location of two distinct services but requires interdisciplinary communication, collaboration, and coordination of service delivery. Furthermore, we now have growing evidence of the benefit and cost-effectiveness of integrated, or what is sometimes called collaborative, care. I’ll mention one example: in the New England Journal of Medicine in 2010, Dr. Katon and colleagues reported on a study of patients with co-occurring depression, poorly-controlled diabetes, and coronary heart disease. The collaborative intervention group outperformed the controls on all measures at 12 months, including cholesterol levels, systolic blood pressure, depression scores, quality of life, and satisfaction with care. As new models of health care such as medical homes and accountable care organizations come online, psychiatry needs to be at the table.

This year, I appointed a new Board of Trustees work group on the role of psychiatry in health care reform chaired by Paul Summergrad, M.D. Paul presented the work group’s agenda and timetable to the board at its meeting in March, 2012. The work group emphasized that health care reform is being driven by market forces, whether or not the affordable care act remains intact (and we await the judgment of the Supreme Court on that question). I believe there is growing recognition and receptivity within medicine at large of the critical importance of our partnership with medicine and primary care. Our participation in the American Medical Association has never been stronger, with many of our members in key positions of leadership, in particular Jeremy Lazarus, M.D. as the current President-Elect of the AMA.

Other groups in organized medicine also understand the central importance of psychiatry, as new models of care evolve. Let me read you a quote from a recent document on the patient-centered medical home being developed jointly by the American Academy of Family Physicians, the American Academy of Pediatrics, the American College of Physicians, and the American Osteopathic Association: science has rendered untenable the implausible and artificial division of people into parts, particularly mental and physical parts.

Given that over half of primary care patients have a mental or behavioral diagnosis or symptoms that are significantly disabling, given that every medical problem has a psychosocial dimension, and given that most personal care plans require substantial health behavior change, a patient-centered medical home would be incomplete without behavioral healthcare expertise and treatment support fully incorporated into its fabric. A whole person orientation simply cannot be imagined without including the behavioral together with the physical.

Meanwhile, significant achievements have been made in the last 10 years in many areas of our vision for mental health. Though stigma continues to be a huge problem for our patients and our field, I believe we are making progress. The mainstream medical nature of depression, for example, is becoming well-known, and I think depression is coming “out of the closet,” just as cancer did years ago. The same is true for some anxiety disorders, such as PTSD, and for alcohol use disorders. Other conditions will take more time, but we’ll get there. The technology of neuroscience research is expanding rapidly, extending the promise of new treatments and of improved capacity to match the right treatment to the individual patient.

And, of course, we celebrate the Wellstone-Domenici Mental Health Parity Act of 2008, a landmark culmination of a long- and hard-fought battle by a cast of thousands. But even as we adjust to the new law, we learn of companies that are looking for loopholes. Our Department of Government Relations, Office of Health Care Systems and Finance, and our new in-house counsel are aggressively monitoring for such situations and are actively intervening when they find them, in collaboration with our state associations and district branches. The same is true on other fronts, such as scope of practice. These and other challenges need our well-orchestrated and sustained attention.

The workforce issue remains a huge concern, illustrated by this year’s drop in the percentage of graduating medical students choosing psychiatry as a specialty. I’m told that medical students these days say that “the road to happiness” is to choose any one of four specialties: anesthesiology, dermatology, ophthalmology, or radiology. You are guaranteed plenty of business, a good income, controllable hours, and minimal night call. But students who do choose to go into psychiatry say they want to have time to spend with patients, to understand what goes wrong (and why) when thoughts, feelings, and self-control get out of balance. And most of all, they want to connect with their future patients in human relationships of healing.

I, for one, believe that the fundamentals of the therapeutic relationship define our profession at its best and are the heart and soul of patient-centered psychiatric medicine. This is the real road to happiness. I would like to elaborate a bit on this last point, as I bring these remarks to a close.

We all have formative moments early in our careers, and one of mine was the opportunity, when I was a resident, to hear Donald W. Winnicott present a talk at the New York Psychoanalytic Society, entitled “The Use of an Object.” Though his terminology seems antiquated now (“object” referred to the analyst), the relevance and vitality of his message has stayed with me. In essence, he argued that for patients to benefit from treatment, they must accept the therapist’s independent existence. Winnicott said, “It is the patient and only the patient who has the answers” and that “[w]e all hope our patients will finish with us, and that they will find living itself to be the therapy that makes sense.” A recovery model, if I ever heard one! Of course not all patients will “finish with us,” and a recovery model includes appropriate continuing care, just as we continue to see our cardiologists, endocrinologists, and ophthalmologists. But others can and should finish with us.

Let me mention two examples from my own experience, one of a patient who needed continued treatment and support, and one of a patient who needed to finish and did so. The first patient, let’s call her Elaine, saw me in the community psychiatry clinic once a month and was maintained on antipsychotic medication. Between appointments, she would telephone me frequently, and I always took her calls. I would answer the phone and there would be silence. I’d say, “Elaine, is that you,” and she would hesitantly answer, “oh…I just wanted to know if you were there.” She was then fine until either her next appointment or her next phone call. Her sense of “object constancy” was shaky, and I wondered how things would go for her down the road. After I moved away, I saw her by chance many years later on a return visit to New York. She recognized me right away and came over to say hello with a big smile. She was still being followed in the community clinic and was still on medication, but she had done pretty well, and she proudly introduced me to her husband.

The second patient, Dr. B, was a severely obsessional young man whom I saw three times a week for several years. He had a doctorate but had not been given tenure at a well-known university, due to his work paralysis. He felt ashamed that he had failed in academia and had had to resort to a job in industry. He was bewildered about why his wife had left him, though he said she told him it was because she could never get any real feelings out of him. He was an unhappy man.

After some time in treatment, I thought I understood how his wife must have felt. Dr. B was always punctual, courteous and cooperative, eagerly trying to please me. But the sessions were amazingly sanitized, colorless, and cerebral. At one point, I interrupted him and said something like “you know, I wonder if you have any idea how hard you are on me?” He was thunderstruck; “what do you mean,” he said. “I do everything I can to please you. I work hard to think about everything you say or suggest. I don’t know what else I could do.” Sounding, I’m sure, a bit like his ex-wife, I said, “That’s just it! You don’t let me exist. You don’t let me be a real person in the room with you. You never disagree with me, you never get angry,” etc., etc. – you get the picture. And, yes, we could have an interesting discussion about what we might call my “deviation from technical neutrality.”

For a while, Dr. B thought I might as well have been speaking a foreign language. However, as time went on, it became clear that my impulsive intervention had stimulated a turning point in treatment. He gradually revealed that after his mother had died when he was 4, he felt desolate and isolated, never able to connect with his distant father or, later, his disapproving, perfectionistic step-mother. He had kept secret memorabilia of his real mother in the attic, where he would go to soothe himself.

It became clear that for him to emotionally connect with a present-day human being, he would have to let his real mother really die. Eventually, he did so. After a while, he re-married, and he achieved for the third time a warm, mutual relationship. The first time was with his real mother, but that was when he was a young boy. The second time was with me. He gave me a big bear hug on termination, later sending me photos of his kids. Thinking back on his case now makes me circle back to Winnicott’s talk in New York. I remember that he finished his talk with a case example, describing the end of the analysis this way: “for my patient, an object now existed in the world, and his world could begin.”

What am I getting at? Here’s the point I’m trying to make. As we wrestle with changes in health care, battle to sustain parity for our patients, fight to improve reimbursement rates, educate about the effectiveness of psychiatric treatment (and here I mean comprehensive medical psychotherapy and pharmacotherapy), work tirelessly to combat stigma, and pursue all of the values so carefully articulated a decade ago in the APA’s vision for the mental health system, and as we embrace integrated care in partnership with the rest of medicine, we need to remember, as with my patient Elaine, to be there for our patients. Actually, it takes more than remembering – we need to insist on the essential healing nature of the therapeutic relationship.

I’m indebted to Walt Menninger for bringing my attention recently to an article in Fortune Magazine in April 1935, which was a special feature on well-known “sanitariums” at the time. Fortune referred to three basic principles involved in “the Menninger therapy”:

  1. The synthesis of the medical and psychological approach,
  2. The individualization of treatment, and
  3. What “Freudians” would have called “transference” but what Dr. Karl Menninger called “scientifically controlled friendship.”

That’s a term I hadn’t come across before, but it gets right at what I’m talking about.

Over 100 years earlier, in a letter dated September 24, 1810 to the managers of the Pennsylvania Hospital, Benjamin Rush stated, in the language of his day: “there is a great pleasure in combatting with success a violent bodily disease, but what is this pleasure compared with that of restoring a fellow creature from the anguish and folly of madness and of reviving in him the knowledge of himself, his family, his friends, and his God!”

So in closing, I call upon all of us to stay the course and to protect the heartbeat of our field – our healing partnerships with our patients, which can and must define how we collaborate with our colleagues as we develop new models of integrated care. It has been a privilege to serve as your President this year. I have worked closely with Dilip Jeste, M.D. and I am confident that we will be in good hands under his leadership.

I could not have served you well this year without the help of the board, the assembly, the APA staff, my great and supportive colleagues at the Menninger Clinic and the Baylor Department of Psychiatry, and especially my wife, Dr. Karen Oldham, who has been very patient with her absentee husband!

Finally, I would like to acknowledge the help of all of the members of the APA. You have all “been there” for me, as I hope I have been, for you.

Thank you very much.

– John M. Oldham, M.D.

Forum Will Analyze Impact of Extreme Events on Human Psyche

A forum today co-sponsored by the American Association of Social Psychiatry (AASP) and the World Association for Social Psychiatry will analyze several historic events and their impact on the human psyche.

“Witness to an Extreme Century” will begin at 11 a.m. in Room 103A, Level 1, Pennsylvania Convention Center. During the hour and a half session, three speakers will share the expertise they’ve gained from studying these life-altering events. Following their presentations, the AASP Humanist Award will be presented to Robert Jay Lifton, M.D., Lecturer in Psychiatry at Columbia University College of Physicians and Surgeons and Distinguished Emeritus Professor of Psychiatry and Psychology at the City University of New York.

Dr. Lifton is a prolific author noted for his studies of the psychological causes and effects of war and political violence, and for his theory of thought reform. He will discuss the major studies described in his memoir, Witness to an Extreme Century. These include his work on Chinese thought reform or brainwashing, his study of atomic bomb survivors in Hiroshima, his work with anti-war Vietnam veterans, and his study of Nazi doctors.

“I’ll suggest ways in which my findings in each of these studies have relevance for our country today,” Dr. Lifton said. “I’ll describe what I have come to call an ‘atrocity-producing situation’ which existed in the war in Vietnam and more recently in Iraq and Afghanistan.”

Dr. Lifton became interested in the world’s destructive possibilities after he was drafted into the military in the 1950s at the end of the Korean War in what he describes as a “liberating experience.” Following his stint as an Air Force psychiatrist, he developed a method of studying the destructive events of humanity that involves extensive interviewing combined with an immersion into the cultural and historical issues surrounding a particular event.

During his lecture, Dr. Lifton will discuss the ways that extreme environments can influence the behavior of people from different backgrounds. He’ll also introduce his work on the protean self, a concept that describes the individual as many-sided, changeable, and more fluid than earlier concepts of the nature of the self.

Dr. Lifton’s work has led him into activism. His lecture will stress his commitment to social activism in combating destructive events, including his opposition to stockpiling nuclear weapons and their potential use.

“I would hope that people could recognize the constructive potential interaction of scholarship and activism. Sometimes they are considered antithetical to each other but I believe each requires the other; that scholarship is given purpose by activism and activism directed by scholarship,” Dr. Lifton said.

“I would also hope that people, whether they are clinicians or whatever their relation to psychiatry is, would see the relevance of these historical events that define our era for their own work and their own lives,” he said. “And I would hope psychiatrists come to recognize the enormous power of extreme environments that can take over from childhood influences.”

Dr. Lifton will be joined in the session by Steven S. Sharfstein, M.D., M.P.A., and Henri Parens, M.D. Dr. Sharfstein, who is President and Chief Executive Officer of Sheppard Pratt Health System, will discuss human rights in the ongoing war on terrorism. Dr. Parens, who is a child survivor of the Holocaust and author of Renewal of Life: Healing from the Holocaust, will describe how survivors are perpetually suspended between concealment and disclosure, how the emotional scars from their wounds are always in the healing process, and how those scars will always impact their lives even if they are invisible to others.